Rockwell Medical Inc (NASDAQ: RMTI), a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease, announced yesterday that it has named Angus Smith as its new chief financial officer effective at the end of November 2018.

Smith will be responsible for managing all financial operations and investor relations activities for the company.

Smith will join Rockwell Medical from Pernix Therapeutics where he currently serves as senior vice president, chief business officer and principal financial officer. Prior to this role, he served as vice president, Business Development & Strategic Planning, and as vice president, M&A and Corporate Finance. Prior to joining Pernix, he worked in healthcare investment banking, most recently serving as a director in the Healthcare Investment Banking Group at Cantor Fitzgerald. During his nearly decade-long investment banking tenure, he focused on providing strategic and financial advice to specialty pharmaceutical and healthcare companies.